- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 36, Issue 6, Pages 1036-1079
Publisher
Wiley
Online
2016-07-13
DOI
10.1002/med.21399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aurora B Expression as a Prognostic Indicator and Possibile Therapeutic Target in Oral Squamous Cell Carcinoma
- (2017) G. Pannone et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion
- (2016) Jessica Konen et al. MOLECULAR BIOLOGY OF THE CELL
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
- (2016) Edmilson Ozorio dos Santos et al. Molecular Cancer
- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
- (2016) Feimeng Zheng et al. Nature Communications
- Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
- (2015) Kiyokazu Tamotsu et al. BMC CANCER
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
- (2015) Bohuslav Melichar et al. LANCET ONCOLOGY
- Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer
- (2015) Chang-Han Chen et al. Molecular Cancer
- p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
- (2015) J. J. Tentler et al. MOLECULAR CANCER THERAPEUTICS
- Spindle assembly checkpoint inactivation fails to suppress neuroblast tumour formation in aurA mutant Drosophila
- (2015) Renaud Caous et al. Nature Communications
- Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells
- (2015) Ling-Zhi Xu et al. Oncotarget
- Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model
- (2015) Daniel Benten et al. NEOPLASIA
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks
- (2014) Huizhen Sun et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells
- (2014) A. E. Vilgelm et al. CANCER RESEARCH
- Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis
- (2014) Gowrikumar Saiprasad et al. EUROPEAN JOURNAL OF CANCER
- Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013)
- (2014) Chun Hei Antonio Cheung et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Prostate cancer with Paneth cell–like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification
- (2014) Kyung Park et al. HUMAN PATHOLOGY
- Rac1 and Aurora A regulate MCAK to polarize microtubule growth in migrating endothelial cells
- (2014) Alexander Braun et al. JOURNAL OF CELL BIOLOGY
- A non-mitotic role for Aurora kinase A as a direct activator of cell migration upon interaction with PLD, FAK and Src
- (2014) M. Mahankali et al. JOURNAL OF CELL SCIENCE
- Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs
- (2014) Ching-Shiun Ke et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- -Catenin Links von Hippel-Lindau to Aurora Kinase A and Loss of Primary Cilia in Renal Cell Carcinoma
- (2014) R. Dere et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
- (2014) Jie Xu et al. Journal of Translational Medicine
- Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma
- (2014) N. Li et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Small Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor-Initiating Cells and Overcomes Drug Resistance
- (2014) F.-M. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- Aurora Kinase Inhibition Induces PUMA via NF- B to Kill Colon Cancer Cells
- (2014) J. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Cyclin B2 and p53 control proper timing of centrosome separation
- (2014) Hyun-Ja Nam et al. NATURE CELL BIOLOGY
- Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells
- (2014) Mateusz Opyrchal et al. PLoS One
- Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: Implications for stem cell mitosis and centrosome dynamics
- (2014) Mariella Mannino et al. Stem Cell Research
- Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL
- (2013) L. Mazzera et al. BLOOD
- A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
- (2013) Satoko Yamamoto et al. BMC CANCER
- A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
- (2013) Karoline Kollmann et al. CANCER CELL
- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2013) Markus Brockmann et al. CANCER CELL
- Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
- (2013) Seiichi Okabe et al. Cancer Cell International
- Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
- (2013) Irena Horwacik et al. CANCER LETTERS
- NEDD9 Depletion Destabilizes Aurora A Kinase and Heightens the Efficacy of Aurora A Inhibitors: Implications for Treatment of Metastatic Solid Tumors
- (2013) R. J. Ice et al. CANCER RESEARCH
- The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma
- (2013) Shi-Yun Cui et al. CELL CYCLE
- USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase
- (2013) S Giovinazzi et al. CELL DEATH AND DIFFERENTIATION
- BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1
- (2013) M Moustafa-Kamal et al. CELL DEATH AND DIFFERENTIATION
- Cell division: control of the chromosomal passenger complex in time and space
- (2013) Armando van der Horst et al. CHROMOSOMA
- The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo
- (2013) N. Zhou et al. CLINICAL CANCER RESEARCH
- Assessment of Aurora a Kinase Expression in Breast Cancer: A Tool for Early Diagnosis?
- (2013) Imen Ferchichi et al. DISEASE MARKERS
- Aurora A kinase and its substrate TACC3 are required for central spindle assembly
- (2013) Antonios Lioutas et al. EMBO REPORTS
- Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
- (2013) Ahmed Katsha et al. GASTROENTEROLOGY
- Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cellsviaAKT signaling
- (2013) Jing Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora A is involved in central spindle assembly through phosphorylation of Ser 19 in P150Glued
- (2013) David Reboutier et al. JOURNAL OF CELL BIOLOGY
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
- (2013) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma
- (2013) Carmelle Romain et al. JOURNAL OF PEDIATRIC SURGERY
- Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer
- (2013) Masafumi Takeshita et al. LUNG CANCER
- The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines
- (2013) Lifang Xie et al. MELANOMA RESEARCH
- Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism
- (2013) L.-L. Liu et al. MOLECULAR CANCER RESEARCH
- AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models
- (2013) Tammy L. Bush et al. MOLECULAR CANCER THERAPEUTICS
- The nephronophthisis gene product NPHP2/Inversin interacts with Aurora A and interferes with HDAC6-mediated cilia disassembly
- (2013) M. Mergen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases
- (2013) M Marxer et al. ONCOGENE
- Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
- (2013) T-V Do et al. ONCOGENE
- The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells
- (2013) A B D'Assoro et al. ONCOGENE
- Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
- (2013) X Q Zheng et al. ONCOGENE
- Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
- (2013) Jie Xu et al. PLoS One
- The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumoursin vitro
- (2013) K. Shiomitsu et al. Veterinary and Comparative Oncology
- Aurora A Kinase Regulates Mammary Epithelial Cell Fate by Determining Mitotic Spindle Orientation in a Notch-Dependent Manner
- (2013) Joseph L. Regan et al. Cell Reports
- Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
- (2012) Zhengzhi Zou et al. Autophagy
- Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients
- (2012) Wulf Siggelkow et al. BMC CANCER
- Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
- (2012) Warren Fiskus et al. BREAST CANCER RESEARCH AND TREATMENT
- Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
- (2012) H R Ali et al. BRITISH JOURNAL OF CANCER
- Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer
- (2012) E Dotan et al. BRITISH JOURNAL OF CANCER
- Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells
- (2012) Y Lin et al. BRITISH JOURNAL OF CANCER
- The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas
- (2012) Vikas Sehdev et al. CANCER
- Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73
- (2012) Hiroshi Katayama et al. CANCER CELL
- Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer
- (2012) C.-H. Chou et al. CANCER RESEARCH
- p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
- (2012) Chun-Chi Wu et al. CELL CYCLE
- Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas
- (2012) Norman L. Lehman et al. CELL CYCLE
- Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2012) A. Cervantes et al. CLINICAL CANCER RESEARCH
- Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
- (2012) K. J. Brewer Savannah et al. CLINICAL CANCER RESEARCH
- Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
- (2012) J. R. Diamond et al. CLINICAL CANCER RESEARCH
- Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma
- (2012) D. Mahadevan et al. CLINICAL CANCER RESEARCH
- Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft Model
- (2012) K. Fraedrich et al. CLINICAL CANCER RESEARCH
- Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations
- (2012) E. C. Dees et al. CLINICAL CANCER RESEARCH
- Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH
- (2012) Fábio Morato de Oliveira et al. EXPERIMENTAL HEMATOLOGY
- Danusertib, an aurora kinase inhibitor
- (2012) Hielke J Meulenbeld et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
- (2012) Ursula A. Matulonis et al. GYNECOLOGIC ONCOLOGY
- Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism
- (2012) Kevin R. Kelly et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cells
- (2012) Akihito Inoko et al. JOURNAL OF CELL BIOLOGY
- Cancer Cell Resistance to Aurora Kinase Inhibitors: Identification of Novel Targets for Cancer Therapy
- (2012) Rita Hrabakova et al. JOURNAL OF PROTEOME RESEARCH
- Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells
- (2012) Aarthi Jayanthan et al. LEUKEMIA & LYMPHOMA
- Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment
- (2012) Wenqing Qi et al. LEUKEMIA RESEARCH
- Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis
- (2012) Olga V. Plotnikova et al. MOLECULAR BIOLOGY OF THE CELL
- Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
- (2012) Fei Fei et al. Molecular Cancer
- Overexpression of Aurora-A Enhances Invasion and Matrix Metalloproteinase-2 Expression in Esophageal Squamous Cell Carcinoma Cells
- (2012) X. Wang et al. MOLECULAR CANCER RESEARCH
- An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
- (2012) K. E. Hook et al. MOLECULAR CANCER THERAPEUTICS
- The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
- (2012) V. Sehdev et al. MOLECULAR CANCER THERAPEUTICS
- Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function
- (2012) Yanli Li et al. MOLECULAR CARCINOGENESIS
- The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
- (2012) Mar Carmena et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
- (2012) Abhinav Grover et al. PLoS One
- Tanshinones Inhibit the Growth of Breast Cancer Cells through Epigenetic Modification of Aurora A Expression and Function
- (2012) Yi Gong et al. PLoS One
- A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
- (2011) H.- T. Arkenau et al. ANNALS OF ONCOLOGY
- Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells
- (2011) Chun Chi Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
- (2011) Wenqing Qi et al. BIOCHEMICAL PHARMACOLOGY
- Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation
- (2011) Jennifer Y. Pan et al. CANCER
- Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
- (2011) L. Kretzner et al. CANCER RESEARCH
- Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway
- (2011) Ilana Chefetz et al. CELL CYCLE
- Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide
- (2011) L. Santo et al. CLINICAL CANCER RESEARCH
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
- (2011) Patrick Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 – 10)
- (2011) Chun Hei Antonio Cheung et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas
- (2011) Wenqing Qi et al. INTERNATIONAL JOURNAL OF CANCER
- MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation
- (2011) Luigi Moretti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells
- (2011) Duo-Rong Xu et al. Journal of Translational Medicine
- Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation
- (2011) Marco Lo Iacono et al. Journal of Translational Medicine
- A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines
- (2011) Aparajita Chowdhury et al. LEUKEMIA & LYMPHOMA
- AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma
- (2011) Fan Yang et al. MODERN PATHOLOGY
- The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
- (2011) A. Faisal et al. MOLECULAR CANCER THERAPEUTICS
- Curcumin-Induced Mitotic Spindle Defect and Cell Cycle Arrest in Human Bladder Cancer Cells Occurs Partly through Inhibition of Aurora A
- (2011) H.-S. Liu et al. MOLECULAR PHARMACOLOGY
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Regulation of APC/CCdc20 activity by RASSF1A–APC/CCdc20 circuitry
- (2011) C Chow et al. ONCOGENE
- Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death
- (2011) V Ratushny et al. ONCOGENE
- In vitroandin vivopharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases
- (2011) Liyue Huang et al. XENOBIOTICA
- Drug-Resistant Aurora A Mutants for Cellular Target Validation of the Small Molecule Kinase Inhibitors MLN8054 and MLN8237
- (2010) Dominic A. Sloane et al. ACS Chemical Biology
- Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
- (2010) J. den Hollander et al. BLOOD
- A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
- (2010) Xiaojing Wang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
- (2010) E. Claire Dees et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
- (2010) Anne M. Traynor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
- (2010) A. Chakravarty et al. CANCER RESEARCH
- Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
- (2010) M. Payton et al. CANCER RESEARCH
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
- (2010) Patrizia Cammareri et al. CANCER RESEARCH
- Aurora A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cellsin vitro
- (2010) Mariko Tomita et al. CANCER SCIENCE
- Aurora Kinases and Protein Phosphatase 1 Mediate Chromosome Congression through Regulation of CENP-E
- (2010) Yumi Kim et al. CELL
- Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2
- (2010) G. Yang et al. CLINICAL CANCER RESEARCH
- Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors
- (2010) J. R. Diamond et al. CLINICAL CANCER RESEARCH
- Pitchfork Regulates Primary Cilia Disassembly and Left-Right Asymmetry
- (2010) Doris Kinzel et al. DEVELOPMENTAL CELL
- Suppression of Aurora-A oncogenic potential by c-Myc downregulation
- (2010) Shangbin Yang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma
- (2010) Heini Lassus et al. GYNECOLOGIC ONCOLOGY
- Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
- (2010) Neeltje Steeghs et al. INVESTIGATIONAL NEW DRUGS
- The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
- (2010) Kevin R. Kelly et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Discovery ofN-Phenyl-4-(thiazol-5-yl)pyrimidin-2-amine Aurora Kinase Inhibitors
- (2010) Shudong Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription Factor
- (2010) Sandy Courapied et al. Molecular Cancer
- MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
- (2010) J. J. Huck et al. MOLECULAR CANCER RESEARCH
- Activity of the Aurora Kinase Inhibitor VX-680 against Bcr/Abl-Positive Acute Lymphoblastic Leukemias
- (2010) F. Fei et al. MOLECULAR CANCER THERAPEUTICS
- ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action
- (2010) G. C. Fletcher et al. MOLECULAR CANCER THERAPEUTICS
- PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
- (2010) Jitesh P. Jani et al. MOLECULAR CANCER THERAPEUTICS
- The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program
- (2010) S Schmidt et al. ONCOGENE
- Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers
- (2010) Kakoli Das et al. PATHOLOGY
- Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
- (2010) I. Astsaturov et al. Science Signaling
- Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
- (2010) Sylvia Scarpini et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients
- (2009) Wei Zhang et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia
- (2009) Nicholas J. Donato et al. BIOCHEMICAL PHARMACOLOGY
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo
- (2009) Jennifer P. Arbitrario et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity
- (2009) S. J. Song et al. CANCER RESEARCH
- A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
- (2009) R. B. Cohen et al. CLINICAL CANCER RESEARCH
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
- (2009) Neeltje Steeghs et al. JOURNAL OF CLINICAL ONCOLOGY
- Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival
- (2009) Jin-e Yao et al. Molecular Cancer
- The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model
- (2009) E. C. VanderPorten et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of a potent and selective Aurora kinase inhibitor
- (2008) Johan D. Oslob et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
- (2008) A. Gontarewicz et al. BLOOD
- Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
- (2008) Altaf A. Dar et al. CANCER RESEARCH
- Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
- (2008) Xiang-Bo Wan et al. CARCINOGENESIS
- Linking Cell Cycle to Asymmetric Division: Aurora-A Phosphorylates the Par Complex to Regulate Numb Localization
- (2008) Frederik Wirtz-Peitz et al. CELL
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- APC/CCdh1 Targets Aurora Kinase to Control Reorganization of the Mitotic Spindle at Anaphase
- (2008) Suzanne Floyd et al. CURRENT BIOLOGY
- Expression of Aurora kinase A and B in normal and malignant cervical tissue: High Aurora A kinase expression in squamous cervical cancer
- (2008) Nae-Fang Twu et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma
- (2008) Abhijit Mazumdar et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
- ConsensusPathDB—a database for integrating human functional interaction networks
- (2008) Atanas Kamburov et al. NUCLEIC ACIDS RESEARCH
- Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
- (2008) A. Seki et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search